Focusing on the Diabetes Patient

Published Online: Friday, November 8, 2013
Follow Pharmacy_Times:
Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, explains why he decided to focus on caring for diabetes patients at his pharmacy. This interview was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.

Related Articles
The introduction of sodium glucose transporter 2 inhibitors has marked a turning point in the management of patients with both type 1 and type 2 diabetes.
Researchers are calling for updated diabetes prevention guidelines that incorporate fetal experiences into the risk equation.
In a large, international study, pioglitazone (Actos) and rosiglitazone (Avandia) did not lead to an increased risk for bladder cancer, contradicting previous studies that suggested the opposite.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$